Nanitebio
Boston, US · Founded 2020 · 15 employees on LinkedIn · 2 known investors
Find your way into Nanitebio
Sign up to see every warm intro you have to Nanitebio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nanitebio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nanite develops resorbable polymer nanoparticles (PNPs) for virus-free genetic drug delivery, using high-throughput synthesis and AI to design precision delivery vectors for gene therapy. It targets subcutaneous gene therapy as an alternative to viral vectors and lipid nanoparticles.
Founders & leadership
Nanitebio was founded in 2020 by Shashi Murthy, Sean Kevlahan, and Thomas Neenan.

Investors · 2
How we know: the VCSheet dataset · Not right? Tell us
How we know: Civilization Ventures Management, Llc's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$4.1M disclosed across 1 round · 2022
▶$4.1MraisedMay 2022 · 11 investors · Other TechnologyRule 506(b)
- Shashi MurthyExecutive Officer
- Sean KevlahanExecutive Officer, Director, Promoter
- Thomas X. NeenanExecutive Officer
- Offering amount
- $6.1M
- Amount sold
- $4.1M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Nanitebio.
Frequently asked questions
- What does Nanitebio do?
- Nanite develops resorbable polymer nanoparticles (PNPs) for virus-free genetic drug delivery, using high-throughput synthesis and AI to design precision delivery vectors for gene therapy. It targets subcutaneous gene therapy as an alternative to viral vectors and lipid nanoparticles.
- Who founded Nanitebio?
- Nanitebio was founded by Shashi Murthy, Sean Kevlahan, Thomas Neenan in 2020.
- Who are Nanitebio's investors?
- Nanitebio's investors include Bantam Group, Civilization Ventures Management, Llc.
- How much funding has Nanitebio raised?
- Nanitebio has disclosed $4.1M raised across 1 round.
- Where is Nanitebio headquartered?
- Nanitebio is headquartered in Boston, US.



